
|Videos|December 13, 2022
CheckMate 9ER: Real World and Health-Related Quality of Life Outcomes
Author(s)Eric Jonasch, MD
Dr Jonasch shares his perspective on CheckMate 9ER in the real-world setting and discusses the trial’s health-related quality-of-life outcomes data investigating nivolumab plus cabozantinib in advanced renal cell carcinoma treatment.
Episodes in this series




















